Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5

Conditions

Endometrial Neoplasms 7Ovarian Neoplasms 6Neoplasms 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Neuroendocrine 2Vulvar Neoplasms 1Vaginal Neoplasms 1Turcot syndrome 1Small Cell Lung Carcinoma 1Sarcoma, Clear Cell 1Sarcoma 1Recurrence 1Penile Neoplasms 1Pathologic Complete Response 1Neoplasms, Second Primary 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1MMRd/MSI-H Stage II-III Endometrial Cancer 1

Interventions

Cisplatin 68Paclitaxel 32Radiotherapy 31Carboplatin 23Bevacizumab 21pembrolizumab 20Brachytherapy 18atezolizumab 11camrelizumab 10Nivolumab 10Gemcitabine 10Drug Therapy 9tislelizumab 8Topotecan 8Taxes 8Chemoradiotherapy 8Radiation 7Docetaxel 7Albumin-Bound Paclitaxel 7zimberelimab 6toripalimab 6nimotuzumab 6Magnetic Resonance Spectroscopy 6Cetuximab 6lenvatinib 5durvalumab 5dostarlimab 5Platinum 5Papillomavirus Vaccines 5Injections 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Uterine Cervical Neoplasms × dostarlimab × Clear all
NCT06023862 2026-05-06

DOVE

Yonsei University

Phase 2 Recruiting
198 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT04068753 2026-02-10

STAR

University of Oklahoma

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07336147 2026-01-14

Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

Chang Gung Memorial Hospital

Phase 2 Recruiting
45 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06238635 2026-01-13

Dostarlimab and Cobolimab in Advanced Cervical Cancer

Beth Israel Deaconess Medical Center

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03833479 2025-05-21

ATOMICC

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Active not recruiting
134 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡